Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Refuerzo JS, Blackwell SC, Sokol RJ, et al. Use of over-the-counter medications and herbal remedies in pregnancy. Am J Perinatology 2005;22:321–324.
Lee E, Maneno MK, Smith L, et al. National patterns of medication use during pregnancy. Pharmacoepid Drug Saf 2006;15:537–545.
Henry A, Crowther C. Patterns of medication use during and prior to pregnancy: the MAP study. Aust N Z J Obstet Gynaecol 2000;40:165–172.
Coad J, Al-Rasasi B, Morgan J. Nutrient insult in early pregnancy. Proc Nutr Soc 2002;61:51–59.
Power ML, Milligan LA, Schulkin J. Managing nausea and vomiting of pregnancy: a survey of obstetrician-gynecologists. J Reprod Med 2007;52:922–928.
American College of Obstetricians and Gynecologists. ACOG practice bulletin #52: nausea and vomiting of pregnancy. Obstet Gynecol 2004;103:803–815.
Borrelli F, Capasso R, Aviello G, Pittler MH, Izzo AA. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 2005;105:849–856.
Chittumma P, Kaewkiattikun K, Wiriyasiriwach B. Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized double-blind controlled trial. J Med Assoc Thai 2007;90:15–20.
Smith C, Crowther C, Willson K, Hotham N, McMillian V. A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy. Obstet Gynecol 2004;103:639–645.
Chuang C, Doyle P, Wang J, et al. Herbal medicines used during the first trimester and major congenital malformations. An analysis of data from a pregnancy cohort study. Drug Saf 2006;29:537–548.
Bsat FA, Hoffman DE, Seubert DE. Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. J Perinatol 2003;23:531–535.
Marcus DA. Nonpharmacologic treatment of migraine. TEN 2001;3:50–55.
Gesch D, Bernhardt O, Alte D, et al. Prevalence of signs and symptoms of temporomandibular disorders in an urban and rural German population: results of a population-based Study of Health in Pomerania. Quintessence Int 2004;35:143–150.
Ballegaard V, Thede-Schmidt-Hansen P, Svensson P, Jensen R. Are headache and temporomandibular disorders related? A blind study. Cephalalgia 2008;28:832–841.
Turk DC, Zaki HS, Rudy TE. Effects of intraoral appliance and biofeedback/stress management alone and in combination in treating pain and depression in patients with temporomandibular disorders. J Prosthet Dent 1993;70:158–164.
Lipton RB, Scher AI, Steiner TJ, Bigal ME, Kolodner K, Lieberman JN, Stewart WF. Patterns of health care utilization for migraine in England and the United States. Neurology 2003;60:441–448.
Streissguth AP, Treder RP, Barr HM, et al. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology 1987;35: 211–219.
Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003; 327:368.
Evers S, Áfra J, Frese A, et al. EFNS guideline on the drug treatment of migraine – report of an EFNS task force. Eur J Neurol 2006;13:560–572.
Kozer E, Nikfar S, Costei A, et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002;187:1623–1630.
Nørgard B, Puhé E, Caeizel AE, Skriver MV, Sørensen HT. Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol 2005;192:922–923.
Klebanoff MA, Berendes HW. Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age. Teratology 1988;437:249–255.
Peroutka SJ, Lyon JA, Swarbrick J, Liption RB, Kolodner K, Goldstein J. Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study. Headache 2004;44:136–141.
Browne ML. Maternal exposure to caffeine and risk of congenital anomalies: a systematic review. Epidemiology 2006;17:324–331.
Browne ML, Bell EM, Druschel CM, et al. Maternal caffeine consumption and risk of cardiovascular malformations. Birth Defects Res A Clin Mol Teratol 2007;79:533–543.
Maizels M, Scott B, Cohen W, Chen W. Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA 1996;276:319–321.
Soldin OP, Dahlin J, O’Mara DM. Triptans in pregnancy. Ther Drug Monit 2008; 30:5–9.
Kallen B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 2001;41:351–356.
Evans EW, Lorber KC. Use of 5-HT1 agonists in pregnancy. Ann Pharmacother 2008;42:543–549.
Bracken MB, Holfod TR. Exposure to prescribed drugs in pregnancy and association with congenital malformations. ObstetGynecol 1981;58:336–344.
Saxén I. Epidemiology of cleft lip and palate. An attempt to rule out chance correlations. Br J Prev Soc Med 1875;29:103–110.
Saxén I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemilol 1975;4:37–44.
Beers MH, Berkow R, eds. Drug use and dependence. The Merck Manual of Diagnostics and Therapeutics, 17th edition, Section 15, Chapter 195. (Available at www.merck.com/pubs Accessed September 30, 2007.)
Göbel H, Fresenius J, Heinze A, Dworschak M, Soyka D. Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension type. Nervenarzt 1996;67:672–681.
Kligler B, Chaudhary S. Peppermint oil. Am Fam Physician 2007;75:1027–1030.
Von Seggern RL, Adelman JU. Practice and economics cost considerations in headache treatment. Part 2: acute migraine treatment. Headache 1996;36:493–502.
Landau DA, Bachner YG, Elishkewitz K, Goldstein L, Barneboim E. Patients’ views on optimal visit length in primary care. J Med Pract Manage 2007;23:12–15.
Woodwell DA, Cherry DK. National Ambulatory Medical Care Survey: 2002 summary. Adv Data 2004;26:1–44.
Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999;39(Suppl 2):S20–S26.
Damase-Michel C, Vié C, Lacroix I, Lapeyre-Mestre M, Montastruc JL. Drug counselling in pregnancy: an opinion survey of French community pharmacists. Pharmacoepidemiol Drug Saf 2004;13:711–715.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Marcus, D.A., Bain, P.A. (2009). Acute Treatment Options for the Pregnant Headache Patient. In: Effective Migraine Treatment in Pregnant and Lactating Women: A Practical Guide. Humana Press. https://doi.org/10.1007/978-1-60327-439-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-60327-439-5_4
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-438-8
Online ISBN: 978-1-60327-439-5
eBook Packages: MedicineMedicine (R0)